Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Clinical trial NCT02040441 · COMPLETED
Trial details
- NCT number
- NCT02040441
- Sponsor
- Peter Rossing
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-11-01
- Enrollment
- 1777
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.